Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05735743

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

End Stage Renal Disease on Dialysis Clinical Trial

Official title:
MoVE Trial: Motivational Strategies To Empower African Americans To Improve Dialysis Adherence

Clinical Trial Summary

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05735743
Study type Interventional
Source Vanderbilt University Medical Center
Contact Ebele M Umeukeje, MD, MPH
Phone 615 936 3283
Email ebele.m.umeukeje@vumc.org
Status Recruiting
Phase N/A
Start date October 9, 2023
Completion date November 1, 2027
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05978479 - The Effect of Individualized Education Using the Teach-Back Method Treatment on Treatment Adherence and the Coping Skills N/A
Completed NCT06022835 - Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis N/A
Completed NCT05540457 - Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis) N/A
Recruiting NCT04046042 - Virtual Reality Intradialysis: Last vs. First Part of the Session N/A
Not yet recruiting NCT04527640 - Effects of Synbiotics Supplementation on the Uremic Toxin Indoxyl Sulfate Level and Constipation in End-stage Renal Disease Patients Undergoing Hemodialysis N/A
Completed NCT05947708 - The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300 N/A
Completed NCT04505462 - Dietary Therapy in Dialysis Patients N/A
Active, not recruiting NCT04546958 - Nutritional Interventions in Peritoneal Dialysis Patients With Hypoalbuminemia N/A
Recruiting NCT04286477 - The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT
Completed NCT04487301 - A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
Recruiting NCT05677555 - Colchicine and Inflammation in Hemodialysis Patients Phase 2
Completed NCT04789876 - Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia N/A
Completed NCT04125537 - Pathways Project: Kidney Supportive Care
Suspended NCT05915286 - Diuretic Use in Hemodialysis Patients With Residual Renal Function Phase 4
Completed NCT04912050 - EXtension of Tablo TrEatmeNt Duration Registry
Recruiting NCT04360694 - RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE) N/A
Recruiting NCT04501159 - pH, Hypoxia and Haemodialysis
Recruiting NCT05032651 - Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients N/A
Completed NCT04806126 - Evaluation of a Virtual Home Dialysis Mentoring Program (Home)
Recruiting NCT05671991 - Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease Phase 4